Нутрициальный подход к профилактике избыточной массы тела новорожденных

1. Donma MM. Macrosomia, top of the iceberg: the charm of underlying factors. Pediatr Int. 2010.
2. Lahmann PH, Wills RA, Coory M. Trends in birth size and macrosomia in Queensland, Australia, from 1988 to 2005. Paediatr Perinat Epidemiol 2009; 23 (6): 533–41.
3. Zhang X, Decker A, Platt RW, Kramer MS. How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol 2008; 198 (5): 517.e1–6.
4. Bjorstad AR, Irgens-Hansen K, Macrosomia: mode of delivery and pregnancy outcome. Acta Obstet Gynecol Scand 2010; 89 (5): 664–9.
5. Wang Y, Gao E, Wu J et al. Fetal macrosomia and adolescence obesity: results from a longitudinal cohort study. Int J Obes (Lond) 2009; 33 (8): 923–8.
6. Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand 2008; 87 (2): 134–45.
7. Henriksen T. Nutrition, weight and pregnancy Tidsskr Nor Laegeforen 2007; 127 (18): 2399–401.
8. Sadeh-Mestechkin D, Walfisch A, Shachar R, Suspected macrosomia? Better not tell. Arch Gynecol Obstet 2008; 278 (3): 225–30.
9. Walsh CA, Mahony RT, Foley ME et al. Recurrence of fetal macrosomia in non-diabetic pregnancies. J Obstet Gynaecol 2007; 27 (4): 374–8.
10. Jolly MC, Sebire NJ, Harris JP. Risk factors for macrosomia and its clinical consequences: a study of 350 311 pregnancies. Eur J Obstet Gynecol Reprod Biol 2003; 111 (1): 9–14.
11. Torshin I.Yu. Bioinformatics in the post-genomic era: physiology and medicine. Nova Biomedical. 2007.
12. Ragnarsdottir LH, Conroy S. Development of macrosomia resulting from gestational diabetes mellitus: physiology and social determinants of health. Adv Neonatal Care 2010; 10 (1): 7–12.
13. Lawlor DA, Fraser A, Lindsay RS. Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia 2010; 53 (1): 89–97.
14. Garcia Carrapato MR. The offspring of gestational diabetes. J Perinat Med. 2003; 31 (1): 5.
15. Chaouachi S, Ben Hamida E, Belhaj R. levels of glycosylated hemoglobin in mothers of large baby: a prospective study Tunis Med 2009; 87 (9): 589–92.
16. Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 2010; 89 (5): 700–4.
17. Cleary-Goldman J, Malone FD. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008; 112 (1): 85–92.
18. Sayin NC, Canda MT, Ahmet N. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Arch Gynecol Obstet. 2008; 277 (1): 47–53.
19. Gillman MW, Oakey H, Baghurst PA. Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care. 2010; 33 (5): 964–8.
20. Landon MB, Spong CY, Thom E. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361 (14): 1339–48.
21. Vasudevan C, Renfrew M, McGuire W. Fetal and perinatal consequences of maternal obesity. Arch Dis Child Fetal Neonatal Ed. 2010.
22. Denguezli W. Risk factors of fetal macrosomia: role of maternal nutrition. Tunis Med. 2009; 87 (9): 564–8.
23. Jaipaul JV. Modifiable risk factors for term large for gestational age births. Health Care Women Int 2009; 30 (9): 802–23.
24. Wang J, Wang SH, Shang LX. Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia. J Obstet Gynaecol Res 2010; 36 (3): 533–7.
25. Axmon A, Rylander L. Birth weight and fetal growth in infants born to female hairdressers and their sisters. Occup Environ Med 2009; 66 (3): 198–204.
26. Voldner N, Froslie KF, Bo K, Haakstad L. Modifiable determinants of fetal macrosomia: role of lifestyle-related factors. Acta Obstet Gynecol Scand 2008; 87 (4): 423–9.
27. Owe KM, Nystad W, Bo K. Association between regular exercise and excessive newborn birth weight. Obstet Gynecol 2009; 114 (4): 770–6.
28. Foley MR, Landon MB. Effect of prolonged oral terbutaline therapy on glucose tolerance in pregnancy. Am J Obstet Gynecol 1993; 168 (1 Pt 1): 100–5.
29. Kallen B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol 2007; 63 (4): 363–73.
30. Fisher JE, Smith RS, Lagrandeur R, Lorenz RP. Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery. Obstet Gynecol 1997; 90 (6): 880–3.
31. Спиричев В.Б., Что такое «рекомендуемые нормы потребности» витаминов и насколько эта норма индивидуальна? Хим. и жизнь 2005; 12.
32. Ребров В.Г., Громова О.А. Витамины, макро- и микроэлементы. M.: ГеотарМед, 2008.
33. Torshin IYu, Gromova OA. Magnesium and pyridoxine: fundamental studies and clinical practice. Nova Science 2009.
34. Громова О.А., Торшин И.Ю. Применение фолиевой кислоты в акушерской практике. Обучающие программы ЮНЕСКО. М., 2009.
35. Oyama K, Folic acid prevents congenital malformations in the offspring of diabetic mice. Endocr J 2009; 56 (1): 29–37.
36. Krishnaveni GV. Low plasma vitamin B12 in pregnancy is associated with gestational 'diabesity' and later diabetes. Diabetologia 2009; 52 (11): 2350–8.
37. Carter P, Gray LJ, Troughton J. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BM. 2010; 341: c4229.
38. Idzior-Walus B. Total plasma homocysteine correlates in women with gestational diabetes. Arch Gynecol Obstet 2008; 278 (4): 309–13.
39. Guven MA, Kilinc M, Batukan C. Elevated second trimester serum homocysteine levels in women with gestational diabetes mellitus. Arch Gynecol Obstet 2006; 274 (6): 333–7. 
40. Tarim E, Bagis T, Kilicdag E, Erkanli S. Elevated plasma homocysteine levels in gestational diabetes mellitus. Acta Obstet Gynecol Scand 2004; 83 (6): 543–7.
41. Hernandez-Diaz S, Werler MM, Louik C. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am J Epidemiol 2002; 156 (9): 806–12.
42. Yajnik CS, Deshpande SS, Jackson AA. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008; 51 (1): 29–38.
43. Terroine T. Biochemical anomalies and teratogenic avitaminosis. Annee Biol 1967; 6 (7): 329–59.
44. Nilsen RM, Vollset SE, Rasmussen SA. Folic acid and multivitamin supplement use and risk of placental abruption: a population-based registry study. Am J Epidemiol 2008; 167 (7): 867–74.
45. Луценко Н.Н. Поливитамины и минералы как неотъемлимая часть питания женщины до, во время и после беременности. РМЖ 2004; 12 (13).
46. Жученко Л.А., Мельникова Е.Н., Степнова С.В. Профилактика врожденных пороков развития у плода поливитаминным комплексом Элевит Пронаталь. Журн. рос. общ. акуш.-гинекол. 2004; 1: 44–5.
47. Васильева И.Ю. Периконцепционная профилактика врожденной патологии. Рус. мед. журн. 2005; 13 (1): 22–4.
48. Czeizel AE. Eur J. Obstetr Gynecol Reproduc Biology 1998: 151–61.
49. Торшин И.Ю., Громова О.А., Ощепкова Е.В. Тер. арх. 2010.
50. Lapillonne A. Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes. Med Hypotheses 2010; 74 (1): 71–5.
51. Holmes VA, Barnes MS. Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. Br J Nutr 2009; 102 (6): 876–81.
52. Maghbooli Z, Hossein-Nezhad A. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008; 24 (1): 27–32.
53. Zhang C, Qiu C, Hu FB et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One 2008; 3 (11): e3753.
54. Громова О.А., Торшин И.Ю., Гарасько Е.В. Топическое назначение витамина С в гинекологической практике. Вопр. акуш. и гинекол. 2010; 10.
55. Zhang C. Maternal plasma ascorbic Acid (vitamin C) and risk of gestational diabetes mellitus. Epidemiology 2004; 15 (5): 597–604.
56. Zhang C. Vitamin C and the risk of gestational diabetes mellitus: a case-control study. J Reprod Med 2004; 49 (4): 257–66.
57. Seghieri G, Martinoli L, Miceli M. Renal excretion of ascorbic acid in insulin dependent diabetes mellitus. Int J Vitam Nutr Res 1994; 64 (2): 119–24.
58. Patterson JW. The diabetogenic effect of dehydroascorbic acid. Endocrinology 1949; 45 (3): 344.
59. De Bastiani G, Granata L. Diabetogenic effect of simultaneous therapy with glucose and dehydroascorbic acid in rat. Boll Soc Ital Biol Sper 1953; 29 (2): 223–4.
60. Merlini D. On diabeted caused by dehydroascorbic acid. Rass Clin Sci 1961; 37: 109–13.
61. Чекман И.С. Магний в медицинской практике. Киев, 1992.
62. de Valk HW. Magnesium in diabetes mellitus. Neth J Med 1999; 54 (4): 139–46.
63. Banerjee S. Prevention of diabetes. J Indian Med Assoc 2003; 101 (12): 698–9.
64. Banerjee S, Mimouni FB, Mehta R et al. Lower whole blood ionized magnesium concentrations in hypocalcemic infants of gestational diabetic mothers. Magnes Res 2003; 16 (2): 127–30.
65. Bardicef M, Bardicef O, Sorokin Y et al. Extracellular and intracellular magnesium depletion in pregnancy and gestational diabetes. Am J Obstet Gynecol 1995; 172 (3): 1009–13.
66. Wang Y, Tan M, Huang Z. Elemental contents in serum of pregnant women with gestational diabetes mellitus. Biol Trace Elem Res 2002; 88 (2): 113–8.
67. Bo S, Lezo A, Menato G, Pagano GF. Gestational hyperglycemia, zinc, selenium, and antioxidant vitamins. Nutrition 2005; 21 (2): 186–91.
68. King IB. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004; Suppl: 2–14.
69. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998; 17 (6): 548–55.
70. Kaczmarek M, Timofeeva OA. The role of ascorbate in the modulation of HIF-1alpha protein and HIF-dependent transcription by chromium (VI) and nickel (II). Free Radic Biol Med 2007; 42 (8): 1246–57.
71. Yessoufou A. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. Int J Obes (Lond) 2006; 30 (5): 739–50.
72. Громова О.А., Торшин ИЮ. Омега-3-полиненасыщенные жирные кислоты в акушерстве и гинекологии. Обучающие программы ЮНЕСКО. М., 2009.
73. Sugimura Y, Murase T, Kobayashi K, Alpha-lipoic acid reduces congenital malformations in the offspring of diabetic mice. Diabetes Metab Res Rev 2009; 25 (3): 287–94.
74. Zhang C, Liu S, Solomon CG, Hu FB. Dietary fiber intake, dietary glycemic load, and the risk for gestational diabetes mellitus. Diabetes Care 2006; 29 (10): 2223–30.

________________________________________________

1. Donma MM. Macrosomia, top of the iceberg: the charm of underlying factors. Pediatr Int. 2010.
2. Lahmann PH, Wills RA, Coory M. Trends in birth size and macrosomia in Queensland, Australia, from 1988 to 2005. Paediatr Perinat Epidemiol 2009; 23 (6): 533–41.
3. Zhang X, Decker A, Platt RW, Kramer MS. How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol 2008; 198 (5): 517.e1–6.
4. Bjorstad AR, Irgens-Hansen K, Macrosomia: mode of delivery and pregnancy outcome. Acta Obstet Gynecol Scand 2010; 89 (5): 664–9.
5. Wang Y, Gao E, Wu J et al. Fetal macrosomia and adolescence obesity: results from a longitudinal cohort study. Int J Obes (Lond) 2009; 33 (8): 923–8.
6. Henriksen T. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand 2008; 87 (2): 134–45.
7. Henriksen T. Nutrition, weight and pregnancy Tidsskr Nor Laegeforen 2007; 127 (18): 2399–401.
8. Sadeh-Mestechkin D, Walfisch A, Shachar R, Suspected macrosomia? Better not tell. Arch Gynecol Obstet 2008; 278 (3): 225–30.
9. Walsh CA, Mahony RT, Foley ME et al. Recurrence of fetal macrosomia in non-diabetic pregnancies. J Obstet Gynaecol 2007; 27 (4): 374–8.
10. Jolly MC, Sebire NJ, Harris JP. Risk factors for macrosomia and its clinical consequences: a study of 350 311 pregnancies. Eur J Obstet Gynecol Reprod Biol 2003; 111 (1): 9–14.
11. Torshin I.Yu. Bioinformatics in the post-genomic era: physiology and medicine. Nova Biomedical. 2007.
12. Ragnarsdottir LH, Conroy S. Development of macrosomia resulting from gestational diabetes mellitus: physiology and social determinants of health. Adv Neonatal Care 2010; 10 (1): 7–12.
13. Lawlor DA, Fraser A, Lindsay RS. Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia 2010; 53 (1): 89–97.
14. Garcia Carrapato MR. The offspring of gestational diabetes. J Perinat Med. 2003; 31 (1): 5.
15. Chaouachi S, Ben Hamida E, Belhaj R. levels of glycosylated hemoglobin in mothers of large baby: a prospective study Tunis Med 2009; 87 (9): 589–92.
16. Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 2010; 89 (5): 700–4.
17. Cleary-Goldman J, Malone FD. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008; 112 (1): 85–92.
18. Sayin NC, Canda MT, Ahmet N. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Arch Gynecol Obstet. 2008; 277 (1): 47–53.
19. Gillman MW, Oakey H, Baghurst PA. Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care. 2010; 33 (5): 964–8.
20. Landon MB, Spong CY, Thom E. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361 (14): 1339–48.
21. Vasudevan C, Renfrew M, McGuire W. Fetal and perinatal consequences of maternal obesity. Arch Dis Child Fetal Neonatal Ed. 2010.
22. Denguezli W. Risk factors of fetal macrosomia: role of maternal nutrition. Tunis Med. 2009; 87 (9): 564–8.
23. Jaipaul JV. Modifiable risk factors for term large for gestational age births. Health Care Women Int 2009; 30 (9): 802–23.
24. Wang J, Wang SH, Shang LX. Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia. J Obstet Gynaecol Res 2010; 36 (3): 533–7.
25. Axmon A, Rylander L. Birth weight and fetal growth in infants born to female hairdressers and their sisters. Occup Environ Med 2009; 66 (3): 198–204.
26. Voldner N, Froslie KF, Bo K, Haakstad L. Modifiable determinants of fetal macrosomia: role of lifestyle-related factors. Acta Obstet Gynecol Scand 2008; 87 (4): 423–9.
27. Owe KM, Nystad W, Bo K. Association between regular exercise and excessive newborn birth weight. Obstet Gynecol 2009; 114 (4): 770–6.
28. Foley MR, Landon MB. Effect of prolonged oral terbutaline therapy on glucose tolerance in pregnancy. Am J Obstet Gynecol 1993; 168 (1 Pt 1): 100–5.
29. Kallen B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications. Eur J Clin Pharmacol 2007; 63 (4): 363–73.
30. Fisher JE, Smith RS, Lagrandeur R, Lorenz RP. Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery. Obstet Gynecol 1997; 90 (6): 880–3.
31. Спиричев В.Б., Что такое «рекомендуемые нормы потребности» витаминов и насколько эта норма индивидуальна? Хим. и жизнь 2005; 12.
32. Ребров В.Г., Громова О.А. Витамины, макро- и микроэлементы. M.: ГеотарМед, 2008.
33. Torshin IYu, Gromova OA. Magnesium and pyridoxine: fundamental studies and clinical practice. Nova Science 2009.
34. Громова О.А., Торшин И.Ю. Применение фолиевой кислоты в акушерской практике. Обучающие программы ЮНЕСКО. М., 2009.
35. Oyama K, Folic acid prevents congenital malformations in the offspring of diabetic mice. Endocr J 2009; 56 (1): 29–37.
36. Krishnaveni GV. Low plasma vitamin B12 in pregnancy is associated with gestational 'diabesity' and later diabetes. Diabetologia 2009; 52 (11): 2350–8.
37. Carter P, Gray LJ, Troughton J. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BM. 2010; 341: c4229.
38. Idzior-Walus B. Total plasma homocysteine correlates in women with gestational diabetes. Arch Gynecol Obstet 2008; 278 (4): 309–13.
39. Guven MA, Kilinc M, Batukan C. Elevated second trimester serum homocysteine levels in women with gestational diabetes mellitus. Arch Gynecol Obstet 2006; 274 (6): 333–7. 
40. Tarim E, Bagis T, Kilicdag E, Erkanli S. Elevated plasma homocysteine levels in gestational diabetes mellitus. Acta Obstet Gynecol Scand 2004; 83 (6): 543–7.
41. Hernandez-Diaz S, Werler MM, Louik C. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am J Epidemiol 2002; 156 (9): 806–12.
42. Yajnik CS, Deshpande SS, Jackson AA. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008; 51 (1): 29–38.
43. Terroine T. Biochemical anomalies and teratogenic avitaminosis. Annee Biol 1967; 6 (7): 329–59.
44. Nilsen RM, Vollset SE, Rasmussen SA. Folic acid and multivitamin supplement use and risk of placental abruption: a population-based registry study. Am J Epidemiol 2008; 167 (7): 867–74.
45. Луценко Н.Н. Поливитамины и минералы как неотъемлимая часть питания женщины до, во время и после беременности. РМЖ 2004; 12 (13).
46. Жученко Л.А., Мельникова Е.Н., Степнова С.В. Профилактика врожденных пороков развития у плода поливитаминным комплексом Элевит Пронаталь. Журн. рос. общ. акуш.-гинекол. 2004; 1: 44–5.
47. Васильева И.Ю. Периконцепционная профилактика врожденной патологии. Рус. мед. журн. 2005; 13 (1): 22–4.
48. Czeizel AE. Eur J. Obstetr Gynecol Reproduc Biology 1998: 151–61.
49. Торшин И.Ю., Громова О.А., Ощепкова Е.В. Тер. арх. 2010.
50. Lapillonne A. Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes. Med Hypotheses 2010; 74 (1): 71–5.
51. Holmes VA, Barnes MS. Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. Br J Nutr 2009; 102 (6): 876–81.
52. Maghbooli Z, Hossein-Nezhad A. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008; 24 (1): 27–32.
53. Zhang C, Qiu C, Hu FB et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One 2008; 3 (11): e3753.
54. Громова О.А., Торшин И.Ю., Гарасько Е.В. Топическое назначение витамина С в гинекологической практике. Вопр. акуш. и гинекол. 2010; 10.
55. Zhang C. Maternal plasma ascorbic Acid (vitamin C) and risk of gestational diabetes mellitus. Epidemiology 2004; 15 (5): 597–604.
56. Zhang C. Vitamin C and the risk of gestational diabetes mellitus: a case-control study. J Reprod Med 2004; 49 (4): 257–66.
57. Seghieri G, Martinoli L, Miceli M. Renal excretion of ascorbic acid in insulin dependent diabetes mellitus. Int J Vitam Nutr Res 1994; 64 (2): 119–24.
58. Patterson JW. The diabetogenic effect of dehydroascorbic acid. Endocrinology 1949; 45 (3): 344.
59. De Bastiani G, Granata L. Diabetogenic effect of simultaneous therapy with glucose and dehydroascorbic acid in rat. Boll Soc Ital Biol Sper 1953; 29 (2): 223–4.
60. Merlini D. On diabeted caused by dehydroascorbic acid. Rass Clin Sci 1961; 37: 109–13.
61. Чекман И.С. Магний в медицинской практике. Киев, 1992.
62. de Valk HW. Magnesium in diabetes mellitus. Neth J Med 1999; 54 (4): 139–46.
63. Banerjee S. Prevention of diabetes. J Indian Med Assoc 2003; 101 (12): 698–9.
64. Banerjee S, Mimouni FB, Mehta R et al. Lower whole blood ionized magnesium concentrations in hypocalcemic infants of gestational diabetic mothers. Magnes Res 2003; 16 (2): 127–30.
65. Bardicef M, Bardicef O, Sorokin Y et al. Extracellular and intracellular magnesium depletion in pregnancy and gestational diabetes. Am J Obstet Gynecol 1995; 172 (3): 1009–13.
66. Wang Y, Tan M, Huang Z. Elemental contents in serum of pregnant women with gestational diabetes mellitus. Biol Trace Elem Res 2002; 88 (2): 113–8.
67. Bo S, Lezo A, Menato G, Pagano GF. Gestational hyperglycemia, zinc, selenium, and antioxidant vitamins. Nutrition 2005; 21 (2): 186–91.
68. King IB. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004; Suppl: 2–14.
69. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998; 17 (6): 548–55.
70. Kaczmarek M, Timofeeva OA. The role of ascorbate in the modulation of HIF-1alpha protein and HIF-dependent transcription by chromium (VI) and nickel (II). Free Radic Biol Med 2007; 42 (8): 1246–57.
71. Yessoufou A. N-3 fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. Int J Obes (Lond) 2006; 30 (5): 739–50.
72. Громова О.А., Торшин ИЮ. Омега-3-полиненасыщенные жирные кислоты в акушерстве и гинекологии. Обучающие программы ЮНЕСКО. М., 2009.
73. Sugimura Y, Murase T, Kobayashi K, Alpha-lipoic acid reduces congenital malformations in the offspring of diabetic mice. Diabetes Metab Res Rev 2009; 25 (3): 287–94.
74. Zhang C, Liu S, Solomon CG, Hu FB. Dietary fiber intake, dietary glycemic load, and the risk for gestational diabetes mellitus. Diabetes Care 2006; 29 (10): 2223–30.

О.А.Громова1, И.Ю.Торшин1,2, Н.К.Тетруашвили3, В.М.Сидельникова3

1. Российский сателлитный центр «Нейробиология» международного института 
микроэлементов ЮНЕСКО, Москва;
2. ГОУ ВПО Ивановская государственная медицинская академия 
(ректор – д-р мед. наук Е.В.Борзов)
3. ФГУ Научный центр акушерства и гинекологии им. В.И.Кулакова Минздравсоцразвития РФ (дир. – акад. РАМН, проф. Г.Т.Сухих), Москва